Axa’s Imperva, Inc. IMPV Stock Holding History

Axa’s Portfolio IMPV Stock Details IMPV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-19,000	Closed	-$730K	–	1351
2016 Q4	$730K	Sell	19,000 -10,000	-34%	-$406K	﹤0.01%	970
2016 Q3	$1.56M	Sell	29,000 -52,000	-64%	-$2.41M	0.01%	817
2016 Q2	$3.48M	Hold	81,000	–	–	0.02%	635
2016 Q1	$4.09M	Sell	81,000 -15,800	-16%	-$760K	0.02%	611
2015 Q4	$6.13M	Buy	96,800 +26,800	+38%	+$1.82M	0.03%	507
2015 Q3	$4.58M	Sell	70,000 -5,000	-7%	-$332K	0.02%	596
2015 Q2	$5.08M	Sell	75,000 -16,000	-18%	-$883K	0.02%	593
2015 Q1	$3.89M	Sell	91,000 -7,000	-7%	-$311K	0.02%	659
2014 Q4	$4.84M	Hold	98,000	–	–	0.02%	565
2014 Q3	$2.82M	Buy	98,000 +38,000	+63%	+$1.03M	0.01%	663
2014 Q2	$1.57M	Hold	60,000	–	–	0.01%	833
2014 Q1	$3.34M	Sell	60,000 -15,000	-20%	-$863K	0.01%	631
2013 Q4	$3.61M	Buy	75,000 +10,000	+15%	+$421K	0.02%	612
2013 Q3	$2.73M	Buy	+65,000	New	+$3.1M	0.01%	672

Other funds holding IMPV

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Axa's IMPV Position: Q1 2017 in Review

Axa sold out of Imperva, Inc. (IMPV) in Q1 2017, closing a stake of 19,000 shares — an estimated $730K sold.

Axa first reported a position in IMPV in Q3 2013 and held it in 14 quarters. The position peaked at $6.13M in Q4 2015. 182 funds tracked by Wall St. Rank hold IMPV as of Q1 2017.

Axa reported no remaining Imperva, Inc. position as of Q1 2017 after selling out during the quarter.
Axa sold 19,000 Imperva, Inc. shares in Q1 2017, an estimated $730K.
Axa first reported a position in Imperva, Inc. in Q3 2013 and held it in 14 quarters.
Axa's Imperva, Inc. position peaked at $6.13M in Q4 2015.
182 funds tracked by Wall St. Rank held Imperva, Inc. as of Q1 2017.

Based on Axa's 13F filing for Q1 2017, filed 11 May 2017.